GlassScriptPhysician profile
Sadi Ramirez Mercado
NPI 1548651870
$549.91
in general payments reported to CMS, 2019-2025
13 companies · $40.84 in 2025
The $40.84 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.18 · 2020: $30.09 · 2022: $180 · 2023: $162 · 2024: $103 · 2025: $40.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $305.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $153.37 | 2020-2022 | |
| Cranial Technologies, INC | $72.87 | 2022-2024 | Doc Band |
| Sanofi Pasteur INC. | $60.46 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $54.06 | 2023-2024 | Gardasil 9, M-M-R II, Vaxelis |
| Phadia US INC. | $43.58 | 2023 | Immunocap |
| Astrazeneca Pharmaceuticals LP | $36.53 | 2019-2023 | Flumist Quadrivalent |
| Supernus Pharmaceuticals, INC. | $28.93 | 2024 | Qelbree |
| Cipher Pharmaceuticals US LLC | $21.07 | 2025 | Natroba, Spinosad |
| Sanofi-Aventis U.S. LLC | $19.77 | 2025 | |
| Ultragenyx Pharmaceutical INC. | $16.82 | 2022 | |
| Nestle Healthcare Nutrition INC. | $16.12 | 2023 | |
| Novo Nordisk INC | $14.33 | 2020 | |
| Seqirus USA INC | $12.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sadi Ramirez Mercado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.